Harmony Biosciences (NASDAQ:HRMY) reported its Q1 earnings results on Tuesday, May 3, 2022 at 07:30 AM.
Here's what investors need to know about the announcement.
Earnings
Harmony Biosciences beat estimated earnings by 75.86%, reporting an EPS of $0.51 versus an estimate of $0.29.
Revenue was up $25.64 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.26 which was followed by a 0.25% increase in the share price the next day.
Here's a look at Harmony Biosciences's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | 0.37 | 0.28 | 0.18 | -0.03 |
| EPS Actual | 0.63 | 0.51 | 0.54 | 0.38 |
| Revenue Estimate | 90.01M | 79.85M | 68.77M | 57.07M |
| Revenue Actual | 91.21M | 80.73M | 73.82M | 59.67M |
To track all earnings releases for Harmony Biosciences visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
